Added to YB: 2026-09-04
Pitch date: 2026-09-02
LMAT [neutral]
LeMaitre Vascular, Inc.
-2.52%
current return
Author Info
No bio for this author
Company Info
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.
Market Cap
$1.9B
Pitch Price
$82.57
Price Target
N/A
Dividend
1.25%
EV/EBITDA
18.87
P/E
28.37
EV/Sales
6.36
Sector
Health Care Equipment and Supplies
Category
growth
LeMaitre Vascular: Betting on Niche Open Surgery Devices
LMAT (needs more research): LeMaitre Vascular’s 20% post-Q2 drawdown merits a closer look given its niche vascular-surgery products, pricing power and improving profitability. Sales grew at a 16% CAGR from 2022-2025, while gross margin reached 71.5% and net margin 23.1%. The key questions are whether pricing can sustain growth as open surgery loses share to endovascular techniques and whether management can improve on 16 successful acquisitions out of 25.
Read full article (6 min)